单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan 430030, Peoples R China;华中科技大学同济医学院附属同济医院肝脏外科[2]Clin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China;[3]UAB, Comprehens Canc Ctr, Dept Med, Div Hematol & Oncol, Birmingham, AL USA;[4]Birmingham Vet Affairs Med Ctr, Birmingham, AL USA;[5]Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China;[6]Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China;[7]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China
Background and Aims Transforming growth factor beta (TGF-beta) suppresses early stages of tumorigenesis, but contributes to the migration and metastasis of cancer cells. However, the role of TGF-beta signaling in invasive prometastatic hepatocellular carcinoma (HCC) is poorly understood. In this study, we investigated the roles of canonical TGF-beta/mothers against decapentaplegic homolog 3 (SMAD3) signaling and identified downstream effectors on HCC migration and metastasis. Approach and Results By usingin vitrotrans-well migration and invasion assays andin vivometastasis models, we demonstrated that SMAD3 and protein tyrosine phosphatase receptor epsilon (PTPR epsilon) promote migration, invasion, and metastasis of HCC cellsin vitroandin vivo. Further mechanistic studies revealed that, following TGF-beta stimulation, SMAD3 binds directly to PTPR epsilon promoters to activate its expression. PTPR epsilon interacts with TGFBR1/SMAD3 and facilitates recruitment of SMAD3 to TGFBR1, resulting in a sustained SMAD3 activation status. The tyrosine phosphatase activity of PTPR epsilon is important for binding with TGFBR1, recruitment and activation of SMAD3, and its prometastatic rolein vitro. A positive correlation between pSMAD3/SMAD3 and PTPR epsilon expression was determined in HCC samples, and high expression of SMAD3 or PTPR epsilon was associated with poor prognosis of patients with HCC. Conclusions PTPR epsilon positive feedback regulates TGF-beta/SMAD3 signaling to promote HCC metastasis.
基金:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572855, 81572427, 81874189, 30973498, 81400653, 31671348]; State Key Project on Infection Diseases of China [2018ZX10723204-003]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M632829]; Graduates' Innovation Fund from Huazhong University of Science and Technology [5003540055]
第一作者单位:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan 430030, Peoples R China;[2]Clin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China;
通讯作者:
通讯机构:[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan 430030, Peoples R China;[2]Clin Med Res Ctr Hepat Surg Hubei Prov, Wuhan, Peoples R China;[5]Minist Educ, Key Lab Organ Transplantat, Wuhan, Peoples R China;[6]Natl Hlth Commiss, Key Lab Organ Transplantat, Wuhan, Peoples R China;[7]Chinese Acad Med Sci, Key Lab Organ Transplantat, Wuhan, Peoples R China
推荐引用方式(GB/T 7714):
Liao Zhibin,Chen Lin,Zhang Xuewu,et al.PTPR epsilon Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-beta Receptor 1[J].HEPATOLOGY.2020,72(3):997-1012.doi:10.1002/hep.31104.
APA:
Liao, Zhibin,Chen, Lin,Zhang, Xuewu,Zhang, Hongwei,Tan, Xiaolong...&Chen, Xiaoping.(2020).PTPR epsilon Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-beta Receptor 1.HEPATOLOGY,72,(3)
MLA:
Liao, Zhibin,et al."PTPR epsilon Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF-beta Receptor 1".HEPATOLOGY 72..3(2020):997-1012